2 Notes on the scope of the guidance
NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.
Groups that are covered
Children, young people and adults with cancer (haematological and solid tumour malignancies) receiving anticancer treatment.
No subgroups needing special consideration have been identified.
Groups that are not covered
Children, young people and adults with neutropenia or neutropenic sepsis not caused by anticancer treatment.
How this guideline was developed
NICE commissioned the National Collaborating Centre for Cancer to develop this guideline. The Centre established a Guideline Development Group (see appendix A), which reviewed the evidence and developed the recommendations.
There is more information about how NICE clinical guidelines are developed on the NICE website. See also NICE's How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS.